Carefin Pharma Llp - Company Profile

It is a business services limited liability partnership based in Tirur, Kerala, India, established in 2023.
2023 Tirur, Kerala, India Active
Last Updated:
Access Report
About Carefin Pharma Llp

Carefin Pharma Llp, a active limited liability partnership, was established on 12 October 2023 in Tirur, Kerala, India. Engaging in commission trade within the business services sector, it holds LLPIN: ACD-3430. Registered under ROC Roc Ernakulam. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Malik Veluthodath Parambil (Designated Partner), Ramseena Cheriyamakanakath (Designated Partner), Shafeer Kurukkal Parambil (Designated Partner). Past directors included Malik Veluthodath Parambil. Its latest date of accounts and solvency statement 31 March 2024. It is based at Ck Tower,15/128, 1S Floor, Moochikal,Opp.Royal Enfie, Tirur, Kerala, 676307.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    ACD-3430

  • Incorporation Date

    12 October 2023

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Ernakulam

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 2 Year, 3 Months
  • Last Filing with ROC 31 Mar 2024
Company report

Carefin Pharma Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Carefin Pharma Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Carefin Pharma Llp?
Current Designated Partners
Name Designation Appointment Date Status
Malik Veluthodath Parambil Designated Partner 12 Oct 2023 Current
Ramseena Cheriyamakanakath Designated Partner 12 Oct 2023 Current
Shafeer Kurukkal Parambil Designated Partner 04 Apr 2025 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Designated Partner 04 Apr 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Carefin Pharma Llp.

Enhance accessibility to Carefin Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Carefin Pharma Llp revenue growth over time
Carefin Pharma Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Carefin Pharma Llp?

Unlock access to Carefin Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Carefin Pharma Llp?

Unlock and access historical data on people associated with Carefin Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Carefin Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Carefin Pharma Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Carefin Pharma Llp
Recent Activity within the Organization
  • Director Appointment

    Shafeer Kurukkal Parambil was appointed as a Designated Partner was appointed as a Designated Partner on 04 Apr 2025 & has been associated with this company since 10 months 3 days . was recorded as a recent event.

  • Annual General Meeting

    Carefin Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was recorded as a recent event.

  • Statement of Assets & Liabilities

    Progress on Carefin Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was documented.

  • Director Appointment

    The activity Malik Veluthodath Parambil was appointed as a Designated Partner was appointed as a Designated Partner on 12 Oct 2023 & has been associated with this company since 2 years 3 months . was completed.

  • Director Appointment

    Ramseena Cheriyamakanakath was appointed as a Designated Partner was appointed as a Designated Partner on 12 Oct 2023 & has been associated with this company since 2 years 3 months . was recorded as a recent event.

  • LLP Incorporation

    The activity Carefin Pharma Llp was registered on 12 Oct 2023 with Roc Ernakulam & aged 2 years 3 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Carefin Pharma Llp?

The LLPIN of Carefin Pharma Llp is ACD-3430.

Where is Carefin Pharma Llp headquartered?

Carefin Pharma Llp is headquartered at Ck Tower,15/128, 1S Floor, Moochikal,Opp.Royal Enfie, Tirur, Kerala, 676307.

When was Carefin Pharma Llp incorporated?

Carefin Pharma Llp was incorporated on 12 October 2023.

Who are the current directors of Carefin Pharma Llp?

The current directors of Carefin Pharma Llp are

What is the primary industry of Carefin Pharma Llp?

The primary industry of Carefin Pharma Llp is Business Services.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available